NEW YORK, Feb. 16 (GenomeWeb News) - WellGen closed a $3-million Series B funding round, the company said today.

 

The capital will be used to begin clinical studies in humans under its obesity and inflammation programs, said the company in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.